STOCKHOLDERS’ EQUITY (Tables)
|
9 Months Ended |
Jan. 31, 2026 |
|---|
| Equity [Abstract] |
|
| SCHEDULE OF ACTIVITY RESTRICTED AND DEFERRED STOCK UNITS |
A
summary of the changes in RSUs and DSUs outstanding during the nine months ended January 31, 2026 follows:
SCHEDULE
OF ACTIVITY RESTRICTED AND DEFERRED STOCK UNITS
| |
|
Restricted
and Deferred
Stock Units |
|
|
Weighted
Average
Grant-Date
Fair Value
Per Share |
|
| Balance at
April 30, 2025 |
|
|
586,461 |
|
|
$ |
9.60 |
|
| Granted |
|
|
84,325 |
|
|
|
19.24 |
|
| Vested
and converted |
|
|
- |
|
|
|
- |
|
| Balance
at January 31, 2026 |
|
|
670,786 |
|
|
$ |
10.81 |
|
|
| SCHEDULE OF STOCK OPTION ACTIVITY |
The
following is a summary of the Company’s stock option activity during the nine months ended January 31, 2026:
SCHEDULE
OF STOCK OPTION ACTIVITY
| |
|
Number
of
Options |
|
|
Weighted
Average
Exercise
Price |
|
|
Weighted
Average
Remaining
Contractual
Life
(Years) |
|
| Balance at April 30, 2025 |
|
|
458,670 |
|
|
$ |
6.86 |
|
|
|
3.77 |
|
| Granted |
|
|
109,588 |
|
|
|
19.24 |
|
|
|
5.00 |
|
| Exercised |
|
|
(8,631 |
) |
|
|
7.65 |
|
|
|
4.54 |
|
| Forfeited |
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Cancelled |
|
|
(2,500 |
) |
|
|
7.52 |
|
|
|
4.79 |
|
| Balance at January 31,
2026 |
|
|
557,127 |
|
|
|
9.28 |
|
|
|
3.39 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Options
exercisable at end of period |
|
|
415,266 |
|
|
$ |
6.78 |
|
|
|
|
|
| Options
expected to vest |
|
|
141,861 |
|
|
$ |
16.60 |
|
|
|
|
|
| Weighted average fair
value of options granted during the period |
|
|
|
|
|
$ |
10.73 |
|
|
|
|
|
|
| SCHEDULE OF STOCK OPTION VALUATION ASSUMPTION |
The
Company used the Black-Scholes model to determine the fair value of stock options granted during the nine months ended January 31, 2026.
In applying the Black-Scholes option pricing model to options granted, the Company used the following assumptions:
SCHEDULE
OF STOCK OPTION VALUATION ASSUMPTION
| Risk-free interest
rate |
|
|
3.83 |
% |
| Dividend yield |
|
|
0.00 |
% |
| Expected volatility |
|
|
62 |
% |
| Contractual and expected term
(in years) |
|
|
5.0 |
|
| Forfeiture rate |
|
|
0.00 |
% |
|
| SCHEDULE OF STOCK BASED EXPENSE FOR STOCK OPTION |
Stock-based
expense for stock options were recorded in the following amounts as reflected in the unaudited condensed consolidated statements of operations:
SCHEDULE
OF STOCK BASED EXPENSE FOR STOCK OPTION
| |
|
For
the three months ended January 31, 2026 |
|
|
For
the three months ended January 31, 2025 |
|
| Compensation
and related taxes — general and administrative |
|
$ |
54,481 |
|
|
$ |
423,106 |
|
| Professional
and consulting fees |
|
|
57,481 |
|
|
|
574,390 |
|
| Total |
|
$ |
111,962 |
|
|
$ |
997,496 |
|
| |
|
For
the nine months ended January 31, 2026 |
|
|
For
the nine months ended January 31, 2025 |
|
| Compensation
and related taxes — general and administrative |
|
$ |
140,623 |
|
|
$ |
437,910 |
|
| Professional
and consulting fees |
|
|
130,831 |
|
|
|
574,390 |
|
| Total |
|
$ |
271,454 |
|
|
$ |
1,012,300 |
|
|
| SCHEDULE OF STOCK WARRANT ACTIVITY |
A
summary of the Company’s outstanding warrants to purchase shares of common stock as of January 31, 2026, and the changes during
the period are presented below:
SCHEDULE
OF STOCK WARRANT ACTIVITY
| |
|
Number
of Warrants |
|
|
Weighted
Average
Exercise
Price |
|
|
Weighted
Average Remaining Contractual
Life
(Years) |
|
| |
|
|
|
|
|
|
|
|
|
| Balance at April 30, 2025 |
|
|
4,443,444 |
|
|
$ |
7.30 |
|
|
|
2.93 |
|
| Granted |
|
|
961,079 |
|
|
|
23.00 |
|
|
|
2.00 |
|
| Exercised |
|
|
(2,181,083 |
) |
|
|
6.76 |
|
|
|
1.89 |
|
| Forfeited |
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Canceled |
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Total
Warrants Outstanding at January 31, 2026 |
|
|
3,223,440 |
|
|
$ |
12.35 |
|
|
|
2.29 |
|
| Warrants
exercisable at end of period |
|
|
3,223,440 |
|
|
$ |
12.35 |
|
|
|
2.29 |
|
| Weighted average fair
value of warrants granted during the period |
|
|
|
|
|
$ |
23.00 |
|
|
|
|
|
|